Home
LTC Pharmacies
Independent Pharmacies
Menu
About Us
LTC Pharmacies
Independent Pharmacies
Latest Updates
Top Issues
Find Your Legislators
Contact Us
Advocacy
Advocacy Tools
Building Relationships
Advocacy Do's and Don'ts
Action Alerts
State
Federal
Menu
Home
Share Your Story
Resources
My Profile
Tell a Friend
About Us
LTC Pharmacies
Independent Pharmacies
Top Issues
Find Your Legislators
Latest Updates
Contact Us
Take Action
Advocacy Tools
Building Relationships
Advocacy Do's and Don'ts
Advocacy
Advocacy Tools
Building Relationships
Advocacy Do's and Don'ts
Latest Updates
Sort By:
Pharmacy Type:
Independent
Long-Term Care
Topics:
ACA
Advocacy
AHCA
AMP
CMS
Controlled Substance
DIR Fees
dispensing fees
Drug Pricing
EPA
FDA
Federal Government
Federal Upper Limits
Florida
Gag Clauses
HHS
HHS Blueprint
Legislative Update
Legislator Visit
Long-Term Care
Managed Care
Medicaid
Medicare Advantage
Medicare Part B
Medicare Part D
NACDS
NCPA
Opioid
Phair Pricing Act
Pharmacy Visit
Provider Status
Senate HELP Committee
State Government
ThoughtSpot
Toolkit
TRICARE
Washington State
WSPA
Clear Filter
Congress Is on Recess – Take Action Now!
Oct 09, 2019
With the U.S. Congress on recess until October 14th, now is the perfect time to reach out and advocate for critical issues impacting your pharmacy. Access resources to aid you in the process of advocating for your pharmacy.
Full story
20 States Pass Pharmacy Benefit Manager (PBM) Transparency Legislation in 2019—State Drug Pricing Legislation Likely to Continue in 2020
Oct 08, 2019
With most of the 2019 state legislative sessions complete, state lawmakers are beginning to look toward legislative priorities for 2020, including new drug pricing legislation.
Full story
Pharmacy DIR Breakthrough! Overwhelming Majority of Senate Finance Committee Members Urge DIR Fee Reform
Sep 17, 2019
Strong bipartisan support from the powerful Senate Finance Committee indicates that DIR fee reform remains a priority issue in the ongoing drug pricing debate.
Full story
Take Action if You Agree Trump Administration Should Reconsider its Pharmacy DIR Decision
Aug 14, 2019
The National Community Pharmacists Association (NCPA) recently issued a call to action to urge pharmacists to ask U.S. Senators on the Senate Finance Committee to sign onto a bipartisan letter addressed to HHS and CMS asking the Administration to revive DIR fee reform for plan year 2021. Take action immediately and urge your Senator to join their committee colleagues as a signatory on this letter.
Full story
Good Neighbor Pharmacy Urges Senate Finance Committee to Address Pharmacy DIR Fees
Jul 26, 2019
Full story
1
2
3
4
5
6
7
8
9
10
...
© Copyright AmerisourceBergen Corporation. All Rights Reserved.